Table 2 Outcome of patients with VARI, VAP, other VARI, and no VARI
From: Ventilator-associated respiratory infection in a resource-restricted setting: impact and etiology
All VARI (n = 92) | VAP (n = 37) | VARI without VAP (n = 55) | No VARI (n = 286) | |
|---|---|---|---|---|
ICU length of stay (days) | 27 (21–37) | 25 (19–37) | 27 (25–38) | 16 (10–28) |
Days ventilated (days) | 22 (15.5–29.5) | 21 (14–28) | 22 (17–31) | 10 (6–16) |
ICU cost (USD) * | 4723 (2778–7783) | 7213 (3011–8329) | 4196 (2726–7193) | 2534 (1493–4407) |
Hospital length of stay (days) | 38 (26–49) | 31 (22–46) | 39.5 (29.5–49) | 25 (14–39) |
Hospital cost (USD)** | 4434 (2656–7822) | 4522 (2716–7990) | 4167 (2658–6985) | 2639 (1555–4576) |
Antibiotics use (DOT) | 31 (18–42.5) | 35 (21–45) | 30 (17–38) | 18 (10–28) |
Antibiotics in hospital before VARI | 73/92 (79.4%) | 28/38 (75.6%) | 45/55 (87.7%) | 255/282 (90.43%) |
In-hospital mortality | 17/91 (18.7%) | 13/37 (35.1%) | 4/54 (7.4%) | 54/277 (19.5%) |